• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

遗传性酪氨酸血症慢性形式中肝癌的发生。

The occurrence of hepatoma in the chronic form of hereditary tyrosinemia.

作者信息

Weinberg A G, Mize C E, Worthen H G

出版信息

J Pediatr. 1976 Mar;88(3):434-8. doi: 10.1016/s0022-3476(76)80259-4.

DOI:10.1016/s0022-3476(76)80259-4
PMID:173827
Abstract

A 5 1/2-year-old child with hepatocarcinoma complicating hereditary tyrosinemia is presented. A review of the literature and an attempted follow-up of previously reported patients with the chronic form of hereditary tyrosinemia have disclosed 16 cases of hepatocarcinoma occurring in 43 patients surviving beyond 2 years of age (37%). This incidence is considerably higher than that generally given for the occurrence of hepatoma in adults with macronodular cirrhosis. Females and males are equally at risk. Additional factors beyond the development of cirrhosis are likely operative in the induction of hepatocarcinoma in patients with this metabolic disorder; those surviving beyond infancy are at considerable risk for the development of fatal hepatic neoplasms.

摘要

本文报告了一名5岁半患遗传性酪氨酸血症并伴有肝癌的儿童。对文献的回顾以及对先前报道的慢性遗传性酪氨酸血症患者的随访尝试发现,在43名存活超过2岁的患者中有16例发生了肝癌(37%)。这一发病率远高于一般成人巨块型肝硬化患者肝癌的发病率。女性和男性患病风险相同。除了肝硬化的发展之外,其他因素可能在这种代谢紊乱患者肝癌的诱发中起作用;那些存活至婴儿期以后的患者发生致命性肝肿瘤的风险相当高。

相似文献

1
The occurrence of hepatoma in the chronic form of hereditary tyrosinemia.遗传性酪氨酸血症慢性形式中肝癌的发生。
J Pediatr. 1976 Mar;88(3):434-8. doi: 10.1016/s0022-3476(76)80259-4.
2
Chromosomal instability in hereditary tyrosinemia type I.I型遗传性酪氨酸血症中的染色体不稳定
Pediatr Pathol. 1990;10(1-2):243-52. doi: 10.3109/15513819009067111.
3
Hereditary tyrosinemia type I (chronic form): pathologic findings in the liver.遗传性I型酪氨酸血症(慢性型):肝脏的病理表现
Hum Pathol. 1989 Feb;20(2):149-58. doi: 10.1016/0046-8177(89)90179-2.
4
[Surgical excision of a hepatoma complicating chronic tyrosinemia (author's transl)].[慢性酪氨酸血症合并肝癌的手术切除(作者译)]
Arch Fr Pediatr. 1980 Mar;37(3):187-90.
5
Serum type III procollagen in children with type I hereditary tyrosinemia.I型遗传性酪氨酸血症患儿的血清III型前胶原
J Pediatr Gastroenterol Nutr. 1999 Jul;29(1):38-41. doi: 10.1097/00005176-199907000-00011.
6
Resolution of the clinical features of tyrosinemia following orthotopic liver transplantation for hepatoma.肝癌原位肝移植后酪氨酸血症临床特征的消退。
J Hepatol. 1986;3(1):42-8. doi: 10.1016/s0168-8278(86)80144-1.
7
Liver cell dysplasia and early liver transplantation in hereditary tyrosinemia.遗传性酪氨酸血症中的肝细胞发育异常与早期肝移植
Mod Pathol. 1990 Nov;3(6):694-701.
8
Hepatic regenerating nodules in hereditary tyrosinemia.遗传性酪氨酸血症中的肝再生结节
AJR Am J Roentgenol. 1987 Aug;149(2):391-3. doi: 10.2214/ajr.149.2.391.
9
Tyrosine and its catabolites: from disease to cancer.酪氨酸及其分解代谢产物:从疾病到癌症
Acta Biochim Pol. 1996;43(1):209-16.
10
Type I hereditary tyrosinaemia: presentation of 11 cases.I型遗传性酪氨酸血症:11例病例报告
J Inherit Metab Dis. 1991;14(5):765-70. doi: 10.1007/BF01799947.

引用本文的文献

1
Precision oncology through next generation sequencing in hepatocellular carcinoma.通过下一代测序实现肝细胞癌的精准肿瘤学
Heliyon. 2025 Jan 17;11(3):e42054. doi: 10.1016/j.heliyon.2025.e42054. eCollection 2025 Feb 15.
2
Liver tumors in children with chronic liver diseases.患有慢性肝病的儿童的肝脏肿瘤
World J Gastrointest Oncol. 2021 Nov 15;13(11):1680-1695. doi: 10.4251/wjgo.v13.i11.1680.
3
Hereditary tyrosinemia type Ⅰ: newborn screening, diagnosis and treatment.遗传性酪氨酸血症 I 型:新生儿筛查、诊断和治疗。
Zhejiang Da Xue Xue Bao Yi Xue Ban. 2021 Aug 25;50(4):514-523. doi: 10.3724/zdxbyxb-2021-0255.
4
Risk Factors, Pathogenesis, and Strategies for Hepatocellular Carcinoma Prevention: Emphasis on Secondary Prevention and Its Translational Challenges.肝细胞癌预防的风险因素、发病机制及策略:重点关注二级预防及其转化挑战
J Clin Med. 2020 Nov 25;9(12):3817. doi: 10.3390/jcm9123817.
5
Long-Term Outcomes and Practical Considerations in the Pharmacological Management of Tyrosinemia Type 1.1 型酪氨酸血症的药物治疗的长期结果和实际考虑
Paediatr Drugs. 2019 Dec;21(6):413-426. doi: 10.1007/s40272-019-00364-4.
6
GSTZ1 deficiency promotes hepatocellular carcinoma proliferation via activation of the KEAP1/NRF2 pathway.GSTZ1 缺失通过激活 KEAP1/NRF2 通路促进肝细胞癌增殖。
J Exp Clin Cancer Res. 2019 Oct 30;38(1):438. doi: 10.1186/s13046-019-1459-6.
7
GSTZ1-1 Deficiency Activates NRF2/IGF1R Axis in HCC via Accumulation of Oncometabolite Succinylacetone.GSTZ1-1 缺乏通过积累致癌代谢物琥珀酰丙酮在 HCC 中激活 NRF2/IGF1R 轴。
EMBO J. 2019 Aug 1;38(15):e101964. doi: 10.15252/embj.2019101964. Epub 2019 Jun 28.
8
Update in global trends and aetiology of hepatocellular carcinoma.肝细胞癌全球趋势与病因学的最新进展
Contemp Oncol (Pozn). 2018;22(3):141-150. doi: 10.5114/wo.2018.78941. Epub 2018 Sep 30.
9
The association between chemical-induced porphyria and hepatic cancer.化学诱导的卟啉症与肝癌之间的关联。
Toxicol Res (Camb). 2018 Jun 1;7(4):647-663. doi: 10.1039/c8tx00019k. eCollection 2018 Jul 1.
10
Hepatocellular Carcinoma: Causes, Mechanism of Progression and Biomarkers.肝细胞癌:病因、进展机制及生物标志物
Curr Chem Genom Transl Med. 2018 Jun 29;12:9-26. doi: 10.2174/2213988501812010009. eCollection 2018.